HOME TRIAL SUPPORT ASSESSMENT
Assessing the Value & Need for Home Trial Support
This tool assesses core areas that should be considered when measuring a protocol’s compatability with our Home Trial Support service. Thetotal score from this exercise can be used as an internal benchmark for assessing which protocols would benefit most from in-home visits.
For each consideration that follows, where robust data is not currently available, please select your best estimate.
1. What percentage of patients in your study will be over the age of 65?
2. What percentage of patients in your study will be below the age of 18?
3. What percentage of patients in your study will be working adults?
4. What percentage of patients in your study will have mobility challenges?
5. Will your study be of a rare disease population?
6. What is the probability that patients will be geographically dispersed?
7. What is the estimated duration of the study and treatment?
8. What frequency of visits to site are required?
9. What is the estimated length of each site visit?
10. What percentage of visits need to be conducted at the site?
11. What is the duration of follow-up without treatment?
Your trials score is % beneficial.
The use of Home Trial Support increases enrollment and retention in clinical trials by reducing the number of patients that are put off from participating due to the burden the trial creates on their lives.
Recruitment and enrollment impact
Home Trial Support improves enrollment at the time of consent, subsequently speeding up recruitment for the study.